dc.contributor.author | Kingston, B | |
dc.contributor.author | Bailleux, C | |
dc.contributor.author | Delaloge, S | |
dc.contributor.author | Schiavon, G | |
dc.contributor.author | Scott, V | |
dc.contributor.author | Lacroix-Triki, M | |
dc.contributor.author | Carr, TH | |
dc.contributor.author | Kozarewa, I | |
dc.contributor.author | Gevensleben, H | |
dc.contributor.author | Kemp, Z | |
dc.contributor.author | Pearson, A | |
dc.contributor.author | Turner, N | |
dc.contributor.author | André, F | |
dc.date.accessioned | 2020-10-14T14:02:53Z | |
dc.date.issued | 2019-01-01 | |
dc.identifier.citation | JCO precision oncology, 2019, 3 | |
dc.identifier.issn | 2473-4284 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4146 | |
dc.identifier.eissn | 2473-4284 | |
dc.identifier.doi | 10.1200/po.19.00130 | |
dc.format | Electronic-eCollection | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | American Society of Clinical Oncology (ASCO) | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.title | Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline PTEN Mutations. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2019-10-03 | |
rioxxterms.versionofrecord | 10.1200/po.19.00130 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0 | |
rioxxterms.licenseref.startdate | 2019-01 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | JCO precision oncology | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research/Molecular Oncology | |
pubs.organisational-group | /ICR/Students | |
pubs.organisational-group | /ICR/Students/PhD and MPhil | |
pubs.organisational-group | /ICR/Students/PhD and MPhil/17/18 Starting Cohort | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research/Molecular Oncology | |
pubs.organisational-group | /ICR/Students | |
pubs.organisational-group | /ICR/Students/PhD and MPhil | |
pubs.organisational-group | /ICR/Students/PhD and MPhil/17/18 Starting Cohort | |
pubs.publication-status | Published | |
pubs.volume | 3 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Molecular Oncology | |
dc.contributor.icrauthor | Kingston, Belinda | |
dc.contributor.icrauthor | Pearson, Alex | |
dc.contributor.icrauthor | Turner, Nicholas | |